Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma

ConclusionsWe propose CTTN for managing OSCC in terms of adjuvant therapy and aftercare. Furthermore, our study reveals new potential targets in CTTN signaling for individualized OSCC therapy.

Source: Head and Neck - November 20, 2018 Category: ENT & OMF Authors: Dominik Horn, Madeleine Gross, Gerhard Dyckhoff, Jennifer Fuchs, Niels Grabe, Wilko Weichert, Esther Herpel, Christel Herold ‐Mende, Peter Lichter, Jürgen Hoffmann, Jochen Hess, Kolja Freier Tags: ORIGINAL ARTICLE Source Type: research